Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, Philanthropy

MEDIA ADVISORY: OWN.CANCER campaign ?Delivering Hope' through activation events during OWN.CANCER Week


CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) --

WHAT:        

As the City of Calgary recognizes April 18-24, 2024 as OWN.CANCER week, the Alberta Cancer Foundation, Alberta Health Services and University of Calgary will be hosting a series of fun activations and initiatives across the city to support OWN.CANCER's fundraising goal of $250 million for the Arthur J.E. Child Comprehensive Cancer Centre, set to open in fall 2024.

Media are invited to attend ?Delivering Hope' on April 19, 2024 at 12:30 p.m. at Bay Court in CF Chinook Centre. This activation will feature a room-sized Amazon-like box that community members can interact with to learn more about the Arthur Child. This activation will run until April 21, 2024 at 9 p.m.

Additionally, in honour of OWN.CANCER week, the Reconciliation Bridge and Calgary Tower will be lit up yellow to generate awareness for the campaign. Also, $5 from every ticket purchased through the OWN.CANCER website for the April 18 Calgary Flames home game will support the campaign.        

WHEN:        

Delivering Hope
Friday, April 19, 2024
12:30-9:00 p.m.
OWN.CANCER will have a life-sized Amazon box focused on ?Delivering Hope' to bring awareness to the Arthur J.E. Child Comprehensive Cancer Centre.

Landmark Light Up
As part of Calgary's OWN.CANCER week, several local landmarks will be lit up yellow in recognition of the OWN.CANCER campaign, including:        

Calgary Flames ? April 18 home game
$5 from every ticket purchased here for the Calgary Flames home game will support the OWN.CANCER campaign.

WHERE:

Delivering Hope
Bay Court ? CF Chinook Mall
6455 Macleod Trail, Calgary, AB T2H 0K8

RSVP:

Media are asked to RSVP for the Delivering Hope activation no later than 9 a.m. (MT) on Friday, April 19, 2024. Complimentary photos and videos can also be arranged.

Media Contact & RSVP to:
Rebecca Hurl
Brookline Public Relations, Inc.
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d55196fd-ea20-4632-9a2c-f12c105eb117



These press releases may also interest you

at 18:50
Forest firefighters ignite change: secure presumptive WSIB coverage for high cancer risk
Ontario's forest firefighters will soon have the same presumptive WSIB coverage that urban firefighters do. Like urban firefighters, forest firefighters are at a higher risk of cancer, heart disease and heart injuries, and post-traumatic stress...

at 18:49
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices
A final FDA rule regulating laboratory-developed tests (LDTs) as medical devices does not address serious concerns raised by ARUP Laboratories and the clinical laboratory community, and the company's stance on the rule has not changed, CEO Andy...

at 18:45
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
Pfizer Inc. and Genmab A/S today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with...

at 18:45
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
Genmab A/S and Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or...

at 18:45
Pond Technologies Holdings Inc. Announces Filing of 2023 Audited Financial Statements and MD&A
Pond Technologies Holdings Inc. (the "Corporation" or "Pond")  announces the filing of the audited consolidated financial statements of the Corporation for the twelve months ended December 31, 2023 and the related management's discussion and analysis...

at 18:45
Memorial Neuroscience Institute First in South Florida to Utilize Latest Aneurysm Treatment Technology
As a veterinarian in Cuba, Xiomara Delgado was used to providing clinical expertise to patients and families. Now retired and living in Miami, the 77-year-old doctor...

More news about Health...


News published on and distributed by: